Clinical Trial Update: Nelfinavir in Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 trial of nelfinavir in systemic lupus erythematosus was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Nelfinavir (nelfinavir)

Snippet

Sponsor: Northwell Health | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED | Results posted: 2020-02-24